Press release —
FrostPharma appoints Pia Renaudin as CEO and strengthens leadership team
FrostPharma announces that Pia Renaudin will become CEO on 1 January 2027. The leadership team is also strengthened by Philip Slätis as Chief Business Development Officer and Johan Lavén as Chief Commercial Officer.
The appointments will support continued growth in specialty pharma, strategic partnerships and international expansion.
“Pia, Philip and Johan strengthen and complement our leadership team. Together, they bring the experience, capabilities and leadership needed to take FrostPharma forward on our rapid growth journey, alongside all our employees.”
Rolf Clason, Chairman of the Board
Pia Renaudin brings more than 25 years of international life science experience, including senior roles at SciBase, Gilead, Nutricia and AstraZeneca.
Founders Clas Lindbergson and Fredrik Andersch will continue to support the company’s long-term development and new business opportunities.
About FrostPharma
FrostPharma is a fast-growing pharmaceutical company with Nordic roots and European reach. The company identifies, develops and commercializes value-adding medicines for patients and healthcare providers.
Contact: Fredrik Andersch, CEO
+46 737 74 40 67
fredrik.andersch@frostpharma.com
Topics
Categories
FrostPharma - A fast-growing pharmaceutical company with European reach with our heritage in the Nordics
Built on a commitment to improving patient care, FrostPharma identifies, develops, and commercializes value-adding medicines. With a strong position across the Nordic region and an expanding presence in selected European markets, we combine local market expertise with international capabilities to bring meaningful treatments to patients and healthcare providers.
Through focused portfolio development, strategic partnerships, and expanding geographic reach, FrostPharma is building a strong European platform for sustainable growth. Our progress so far has been driven by an experienced and dedicated team, and we believe that the same entrepreneurial spirit and hands-on approach will take FrostPharma into its next phase of European growth.